Matt Larew
Stock Analyst at William Blair
(4.70)
# 771
Out of 4,988 analysts
225
Total ratings
60.7%
Success rate
19.6%
Average return
Main Sectors:
Stocks Rated by Matt Larew
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VCYT Veracyte | Reiterated: Buy | n/a | $39.80 | - | 2 | Sep 15, 2026 | |
| GH Guardant Health | Reiterated: Buy | n/a | $179.38 | - | 5 | Sep 8, 2026 | |
| NEO NeoGenomics | Rated: Hold | n/a | $19.91 | - | 2 | Aug 27, 2026 | |
| QGEN Qiagen | Rated: Hold | n/a | $43.33 | - | 3 | Aug 24, 2026 | |
| SERA Sera Prognostics | Reiterated: Buy | n/a | $2.08 | - | 2 | Aug 20, 2026 | |
| MDXH MDxHealth | Reiterated: Hold | n/a | $0.63 | - | 1 | Aug 14, 2026 | |
| TECH Bio-Techne | Reiterated: Hold | n/a | $72.37 | - | 9 | Aug 12, 2026 | |
| MASS 908 Devices | Reiterated: Buy | n/a | $10.53 | - | 14 | Aug 11, 2026 | |
| MRVI Maravai LifeSciences Holdings | Reiterated: Hold | n/a | $6.97 | - | 14 | Aug 7, 2026 | |
| NTRA Natera | Reiterated: Buy | n/a | $369.39 | - | 1 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $76.60 | - | 10 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $29.20 | - | 1 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $105.92 | - | 1 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $7.79 | - | 9 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $21.70 | - | 13 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $421.63 | - | 6 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $53.83 | - | 2 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $166.99 | - | 11 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $124.44 | - | 13 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $77.84 | - | 2 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $28.61 | - | 1 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $15.52 | - | 9 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $24.30 | - | 13 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $176.89 | - | 11 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $651.45 | - | 11 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $362.31 | - | 12 | Jul 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $211.81 | - | 9 | Jul 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.19 | - | 10 | Jul 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $7.88 | - | 12 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $278.06 | - | 1 | Oct 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $82.47 | n/a | 4 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $14.95 | n/a | 1 | Aug 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $10.92 | n/a | 2 | Sep 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | - | n/a | 2 | Aug 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $183.86 | n/a | 4 | Sep 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $320.71 | n/a | 1 | Dec 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $121.75 | n/a | 1 | Nov 21, 2017 |
Veracyte
Sep 15, 2026
Reiterated: Buy
Price Target: n/a
Current: $39.80
Upside: -
Guardant Health
Sep 8, 2026
Reiterated: Buy
Price Target: n/a
Current: $179.38
Upside: -
NeoGenomics
Aug 27, 2026
Rated: Hold
Price Target: n/a
Current: $19.91
Upside: -
Qiagen
Aug 24, 2026
Rated: Hold
Price Target: n/a
Current: $43.33
Upside: -
Sera Prognostics
Aug 20, 2026
Reiterated: Buy
Price Target: n/a
Current: $2.08
Upside: -
MDxHealth
Aug 14, 2026
Reiterated: Hold
Price Target: n/a
Current: $0.63
Upside: -
Bio-Techne
Aug 12, 2026
Reiterated: Hold
Price Target: n/a
Current: $72.37
Upside: -
908 Devices
Aug 11, 2026
Reiterated: Buy
Price Target: n/a
Current: $10.53
Upside: -
Maravai LifeSciences Holdings
Aug 7, 2026
Reiterated: Hold
Price Target: n/a
Current: $6.97
Upside: -
Natera
Aug 7, 2026
Reiterated: Buy
Price Target: n/a
Current: $369.39
Upside: -
Aug 7, 2026
Reiterated: Buy
Price Target: n/a
Current: $76.60
Upside: -
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $29.20
Upside: -
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $105.92
Upside: -
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $7.79
Upside: -
Aug 5, 2026
Reiterated: Buy
Price Target: n/a
Current: $21.70
Upside: -
Aug 4, 2026
Reiterated: Buy
Price Target: n/a
Current: $421.63
Upside: -
Aug 3, 2026
Rated: Hold
Price Target: n/a
Current: $53.83
Upside: -
Aug 3, 2026
Reiterated: Buy
Price Target: n/a
Current: $166.99
Upside: -
Jul 31, 2026
Rated: Hold
Price Target: n/a
Current: $124.44
Upside: -
Jul 31, 2026
Rated: Hold
Price Target: n/a
Current: $77.84
Upside: -
Jul 30, 2026
Reiterated: Buy
Price Target: n/a
Current: $28.61
Upside: -
Jul 29, 2026
Rated: Hold
Price Target: n/a
Current: $15.52
Upside: -
Jul 29, 2026
Reiterated: Buy
Price Target: n/a
Current: $24.30
Upside: -
Jul 28, 2026
Reiterated: Buy
Price Target: n/a
Current: $176.89
Upside: -
Jul 24, 2026
Reiterated: Buy
Price Target: n/a
Current: $651.45
Upside: -
Jul 23, 2026
Reiterated: Buy
Price Target: n/a
Current: $362.31
Upside: -
Jul 22, 2026
Reiterated: Buy
Price Target: n/a
Current: $211.81
Upside: -
Jul 2, 2026
Rated: Hold
Price Target: n/a
Current: $1.19
Upside: -
May 11, 2026
Reiterated: Sell
Price Target: n/a
Current: $7.88
Upside: -
Oct 11, 2025
Upgraded: Buy
Price Target: n/a
Current: $278.06
Upside: -
Oct 8, 2024
Reiterated: Hold
Price Target: n/a
Current: $82.47
Upside: n/a
Aug 22, 2022
Reiterated: Buy
Price Target: n/a
Current: $14.95
Upside: n/a
Sep 22, 2021
Downgraded: Hold
Price Target: n/a
Current: $10.92
Upside: n/a
Aug 4, 2021
Downgraded: Hold
Price Target: n/a
Current: -
Upside: n/a
Sep 11, 2019
Downgraded: Hold
Price Target: n/a
Current: $183.86
Upside: n/a
Dec 3, 2018
Reiterated: Buy
Price Target: n/a
Current: $320.71
Upside: n/a
Nov 21, 2017
Initiated Coverage: Buy
Price Target: n/a
Current: $121.75
Upside: n/a